Detection of Drug-Induced Thrombocytopenia Signals in Children Using Routine Electronic Medical Records

Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions

(2021) Louis Létinier et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Thrombocytopenia during intravenous valproic acid therapy in the neurological intensive care unit

(2020) Dong Wook Kim et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance

(2020) M.S. Ali et al.   OSTEOPOROSIS INTERNATIONAL

Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia

(2020) Caroline Vayne et al.   Journal of Clinical Medicine

Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance

(2019) Suehyun Lee et al.   DRUG SAFETY

Pediatric drug safety signal detection of non-chemotherapy drug-induced neutropenia and agranulocytosis using electronic healthcare records

(2019) Ran Wei et al.   Expert Opinion On Drug Safety

Drug-Induced Thrombocytopenia: Mechanisms and Laboratory Diagnostics

(2019) Elisa Danese et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Pharmacovigilance in China: development and challenges

(2018) Ying Zhao et al.   International Journal of Clinical Pharmacy

Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records

(2017) Suehyun Lee et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification

(2016) Osemeke U. Osokogu et al.   DRUG SAFETY

Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection

(2015) Alexandra C. Pacurariu et al.   DRUG SAFETY

Drug-induced thrombocytopenia in children

(2013) Jessica A. Reese et al.   PEDIATRIC BLOOD & CANCER

Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit

(2013) ZHAORUI ZHANG et al.   Experimental and Therapeutic Medicine

Use of an abnormal laboratory value–drug combination alert to detect drug-induced thrombocytopenia in critically Ill patients

(2012) Lisa M. Harinstein et al.   JOURNAL OF CRITICAL CARE

A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia

(2012) D. M. ARNOLD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antimicrobial Drug-Induced Thrombocytopenia: A Review of the Literature

(2012) Angela Loo et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Profound thrombocytopenia associated with piperacillin in a hemodialysis patient

(2011) M.-T. Yan et al.   CLINICAL NEPHROLOGY

Cefepime-associated thrombocytopenia in a critically ill patient

(2011) Phin Phin Lim et al.   International Journal of Clinical Pharmacy

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods

(2010) J. A. Reese et al.   BLOOD

A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients

(2009) E Ramirez et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Platelet Measurements versus Discharge Diagnoses for Identification of Patients with Potential Drug-Induced Thrombocytopenia

(2009) Maarten J. ten Berg et al.   DRUG SAFETY

Drug-induced thrombocytopenia: pathogenesis, evaluation, and management

(2009) J. N. George et al.   Hematology-American Society of Hematology Education Program

Predictive Value of Alert Triggers for Identification of Developing Adverse Drug Events

(2009) Carlton Moore et al.   Journal of Patient Safety